Biologic discontinuation studies: a systematic review of methods (Q36812580)

16 August 2017

Biologic discontinuation studies: a systematic review of methods (English)

1 reference

16 August 2017

1 reference

Kazuki Yoshida

1

0 references

Sang-Cheol Bae

object named as

Sang-Cheol Bae

4

0 references

Daniel H Solomon

9

object named as

Daniel H Solomon

1 reference

16 August 2017

5

Michael E Weinblatt

1 reference

16 August 2017

3

Arthur Kavanaugh

1 reference

16 August 2017

Yoon-Kyoung Sung

2

1 reference

16 August 2017

Mitsumasa Kishimoto

6

1 reference

16 August 2017

Kazuo Matsui

7

1 reference

16 August 2017

Shigeto Tohma

8

1 reference

16 August 2017

language of work or name

English

0 references

publication date

30 May 2013

1 reference

Annals of the Rheumatic Diseases

16 August 2017

1 reference

16 August 2017

73

1 reference

16 August 2017

3

1 reference

16 August 2017

595-599

1 reference

Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4836605

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4836605

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4836605

Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4836605

Effect of discontinuing TNFalpha antagonist therapy in patients with remission of rheumatoid arthritis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4836605

Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4836605

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203302

Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4836605

Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23723316

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: an observational cohort study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23723316

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23723316

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ANNRHEUMDIS-2013-203302

1 reference

16 August 2017

1 reference

16 August 2017

1 reference